Get in touch at lee_monk@icloud.com
A deeper look ... at my offerings
CONSULTANCY SERVICES
I provide clear, structured support across:
Quality Strategy & QMS Transformation | GLP / GCP Lab / Clinical IVD /
HTA Compliance | Scientific Data Integrity Frameworks & Digital Quality Maturity | Inspection Readiness | Regulatory Risk Mitigation | Risk-Based Auditing | Diagnostic Assessments & Remediation | Quality Culture & Capability Building | Vendor Oversight | ISO Standards Integration | Diagnostic Assessments & Remediation | Mentoring
Core Services
Data Integrity Frameworks
To establish a clear view of data integrity maturity, I assess an organisation’s current systems, processes, controls and behaviours against OECD GLP, WHO, and MHRA GxP data integrity guidance documents (as relevant). This provides an evidence‑based understanding of data integrity gaps relative to the organisation’s operational stage – be it from exploratory research, discovery, preclinical development, or clinical development - and supports the creation of a proportionate remediation programme where required. I then facilitate the design of practical, risk‑based data integrity frameworks that align processes, roles, and governance with regulatory expectations.
Impact: a proportionate, stage‑appropriate approach to data integrity, reduced compliance risk, and a clear pathway to sustainable, inspection‑ready data practices.
QMS Transformation
Whether your organisation needs a Quality Management System (QMS) built from first principles or requires its existing QMS to evolve, I assess structures, processes, and governance to identify where complexity, gaps, or inefficiencies are limiting performance. My experience spans research, preclinical and clinical bioanalysis, ISO 17025‑accredited laboratory systems, clinical IVD and medical laboratory quality systems (ISO 15189), and environments operating under Human Tissue Authority (HTA) requirements. This breadth provides a practical understanding of how quality frameworks function across diverse scientific and regulatory contexts, and the underlying principles translate seamlessly into any GxP setting.
My approach combines innovative QMS design with a willingness to challenge the status quo, ensuring that systems evolve in line with organisational maturity rather than legacy assumptions. I embed proportionate change‑management thinking into every stage of design and transformation, enabling organisations to adopt new ways of working confidently and sustainably.
This results in a clear design or transformation pathway that strengthens compliance, improves usability, and aligns the QMS with operational reality through proportionate design, streamlined documentation, and sustainable governance practices.
Impact: a modern, scalable QMS, improved operational clarity, and a system that supports consistent, confident, and future‑ready quality performance.
Learning Design
When organisations need training that genuinely builds capability, I design learning experiences (such as concise 2 to
3-minute Vyond videos) in close collaboration with the organisation to ensure they reflect real operational practice, organisational scope, and the culture leaders want to strengthen. My learning design work draws from my extensive experience on Data Integrity, GLP topics, GCP Lab/GCLP topics, and HTA requirements, supported by practical case studies and learner assessments that reinforce confident application in real‑world settings.
These co‑designed materials simplify complex concepts, strengthen understanding, and deliver clear, relevant messages through well‑structured content, engaging formats, and targeted delivery.
Impact: sharper organisational alignment, stronger capability building, and more effective knowledge transfer that supports sustainable quality performance.
Additional Services
Risk‑Based Auditing
I design and implement (or facilitate the design & implementation of) risk‑based audit frameworks that focus effort where it matters most - be it on data reliability, process robustness, and regulatory exposure. My approach is holistic and tailored: I consider where your organisation is today, where it aims to go, its stage in the drug‑development journey, and the specific service being sought. Drawing on experience from CRO and Pharma environments, numerous regulatory inspections, and extensive vendor auditing, I ensure each audit is genuinely phase‑ and risk‑appropriate rather than one‑size‑fits‑all.
My audit scope and depth are shaped by regulatory context, recent guidance updates, inspection intelligence and regulatory intelligence, and current 'hot topics' across the relevant regulatory agencies. This moves auditing beyond checklists to deliver experiential, insight‑driven outcomes that strengthen governance, reduce inefficiencies, and enhance inspection readiness.
Impact: smarter prioritisation, reduced audit fatigue, and measurable improvement in data confidence and operational resilience.
Inspection Readiness Strategies
I help organisations build inspection‑ready systems and behaviours that stand up to scrutiny at any time. My experience spans GLP, GCP Lab/GCLP, HTA, ISO 17025, and clinical IVD laboratory contexts. I have led/co‑hosted inspections with the FDA, MHRA, and Belgian regulators, supported GCP Sponsor inspections, and bring additional insight from rare disease clinical trial contexts.
This breadth enables a practical, proportionate approach to readiness that reflects real regulatory expectations and current inspection intelligence. I support teams through readiness assessments, mock inspections, and coaching that strengthens clarity, consistency, and confidence under inspection conditions.
Impact: sustained compliance, improved team assurance, and a proactive culture that treats inspection readiness as business‑as‑usual rather than a last‑minute scramble.
Vendor Governance
When organisations rely on external partners, I can assess vendor capability, oversight structures, and quality performance to ensure that services, data, and deliverables meet required standards. My approach provides holistic, strategic oversight of laboratory‑based risks from early discovery research through to clinical development, enabling governance that is proportionate to scientific context, operational maturity, and regulatory expectations. This supports clear oversight requirements, targeted monitoring, and timely intervention where risks, gaps, or performance issues are identified.
Impact: stronger vendor reliability, improved oversight confidence, and consistent delivery aligned with organisational and regulatory expectations.
Risk Assessments for Processes
I conduct (and/or facilitate the conduct of) structured risk assessments across laboratory and operational processes to identify vulnerabilities, evaluate controls, and define proportionate mitigation strategies. Each assessment is tailored to the organisation’s maturity and regulatory context, ensuring that risk management becomes an integrated, living part of daily operations.
Regulators increasingly expect organisations to demonstrate documented, defensible risk assessments across a wide range of processes and situations. Many activities now require recurring or annual risk reviews (eg vendor oversight, internal audit programmes, and other governance processes) and/or where regulatory requirements or guidance expectations are not fully met, an associated risk assessment is often required to justify the organisational position.
This ensures transparency, traceability, and a clear rationale for decisions that may otherwise be viewed as gaps.
Impact: clearer decision‑making, stronger process ownership, and reduced exposure to compliance and data integrity risks.
Regulatory Intelligence: Impact Assessments for New Regulations & Guidance
I translate (or facilitate the translation of) new or evolving regulations, guidance documents, and standards into practical, actionable impact assessments. This includes mapping requirements to existing procedures, identifying gaps, and supporting timely updates to SOPs and governance frameworks.
Impact: faster adaptation to regulatory change, maintained compliance continuity, and enhanced organisational agility in a shifting global landscape.
SOPs: Impact Assessments for New and/or Updated Procedures
When new or revised SOPs are introduced, I evaluate (or facilitate the evaluation of) their operational and compliance impact across teams and systems. This ensures alignment with existing processes, clarity in responsibilities, and effective communication of changes through targeted training and implementation support.
For example: A significant procedural update, such as the expansion of a Data Integrity SOP from an “ALCOA++‑only” focus to “Data Integrity Principles and Practices across the full Data Lifecycle” focus require more than simply issuing a new version of an SOP. Changes of this scale anticipate a cultural shift in how data integrity is understood and applied. Each affected area therefore needs a structured impact assessment to determine what must change, what new behaviours are required, and what implementation activities are necessary to embed the updated expectations.
If individual teams are left to conduct these assessments independently, they are often approached inconsistently or even deprioritised (due to the perceived enormity of the task). Engaging my consultation skills ensures a consistent, comprehensive, organisation‑wide evaluation, with clear implementation plans that support sustainable adoption of the updated procedure.
Impact: seamless SOP integration, reduced disruption, and consistent application of new standards across the organisation.
Regulatory Risk Mitigation
When organisations face evolving regulatory expectations, I assess exposure across processes, systems, and decision‑making pathways to identify where compliance vulnerabilities may arise. This enables clear prioritisation of risks, proportionate mitigation planning, and timely updates to governance frameworks that strengthen organisational resilience.
For example: A common scenario may arise when exploratory research on clinical‑trial samples (conducted with appropriate consent, naturally) generates data that clinical teams wish to include in the Clinical Trial Report (CTR) or use to inform dosing decisions for subsequent cohorts. In such cases, an exploratory research laboratory can be rapidly catapulted into the GCP/GCP Lab/GCLP regulatory sphere. I can provide swift assessment of the regulatory gaps and define the remediation package required to ensure that any resulting data meet the expectations of clinical regulations, associated guidance, and supporting frameworks such as CSV, Data Integrity, and HTA requirements (where applicable). This prevents unplanned regulatory exposure and ensures that scientifically valuable data remain usable for clinical decision‑making.
Impact: reduced regulatory exposure, improved decision‑making confidence, and a proactive compliance posture that keeps the organisation ahead of emerging requirements.
Diagnostic Assessment & Remediation
When quality, operational, or compliance issues emerge, I can conduct (or facilitate the conduct of) structured diagnostic assessments to identify root causes, evaluate process performance, and determine where controls, behaviours, or systems are breaking down. These diagnostic assessments often require the same level of structure and thoroughness as Regulatory Intelligence (RIN) or SOP Impact Assessments, particularly when triggered by inspection or audit findings that reveal systemic failures and/or gaps within existing processes and procedures.
This approach provides a clear understanding of underlying issues and the actions required to restore compliance, strengthen operational reliability, and prevent recurrence. Where needed, I also facilitate the development of proportionate remediation plans that address both immediate risks and longer‑term system improvements.
Impact: targeted remediation, reduced recurrence of issues, and sustainable improvements that reinforce quality, consistency, and organisational confidence.
Mentoring & Professional Development
When quality professionals need grounded, experience‑based guidance, I provide practical, pragmatic support shaped by years of experience guiding teams through complex situations with clarity and confidence. My mentoring focuses on strengthening decision‑making, building confidence, and helping individuals learn from challenges and missteps rather than feeling they have failed. I offer practical insight, support the development of leadership skills, help people gain clarity in their thinking, and provide experience‑led approaches to resolving issues and navigating career decisions.
This enables individuals to approach complex quality and operational challenges with assurance, capability, and a stronger sense of professional resilience.
Impact: accelerated professional growth, stronger leadership capability, and confident, experience‑led resolution of complex issues.
Contact
I’m always looking for impactful opportunities where my experience makes a difference. Let's connect.